Sigrid Therapeutics AB

https://www.sigridthx.com

Twitter: @SigridThx

LinkedIn: https://www.linkedin.com/company/sigrid-therapeutics-ab

	Start	2014-01-01 established
	Industry	antidiabetic
	Industry 2	SiPore15™ medical device (SiPore® technology)
	Person	Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder)

	Region	Stockholm
	Country	Sweden
	Street	159 Sankt Göransgatan
	City	11217 Stockholm
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Sigrid Therapeutics AB

[1] Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm....
[2] Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)